REVVITY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.3 USD | +1.23% |
|
+2.76% | +3.62% |
| May. 14 | Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM | |
| Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
Chart calendar Revvity, Inc.
e71fb2d183fd17b0dd19d344fc9be4.vd-sMAcwCbEYnsOGPqRfLQPlcjRP7zTSauC4v0Jo7fc.yIDGW1ZWX4gt56HtYdI5ZjecOFY123e9J6_6iQU42aHTqp1TYlo76EL8pA~dfa21cb6a5b590f6c6415d5cae5e338e
Upcoming events on Revvity, Inc.
Past events on Revvity, Inc.
| 2024-05-14 11:40 am | BofA Securities Health Care Conference |
| 2024-04-29 08:00 am | Q1 2024 Earnings Call |
| 2024-04-29 06:00 am | Q1 2024 Earnings Release |
| 2024-04-23 08:00 am | Annual General Meeting |
| 2024-04-17 | Ex-dividend day |
| 2024-03-20 09:00 am | KeyBanc Life Sciences & MedTech Forum |
| 2024-03-12 09:30 am | Barclays Global Healthcare Conference |
| 2024-03-05 09:15 am | Raymond James Institutional Investors Conference |
| 2024-03-04 09:10 am | TD Cowen Health Care Conference |
| 2024-02-29 08:00 am | Citi Unplugged Medtech and Life Sciences Access Day |
| 2024-02-01 08:00 am | Q4 2023 Earnings Call |
| 2024-02-01 06:00 am | Q4 2023 Earnings Release |
| 2024-01-17 | Ex-dividend day |
| 2024-01-09 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-28 09:10 am | Evercore ISI HealthCONx Conference |
| 2023-10-30 08:00 am | Q3 2023 Earnings Call |
| 2023-10-30 06:00 am | Q3 2023 Earnings Release |
| 2023-10-18 | Ex-dividend day |
| 2023-09-14 08:20 am | Bank of America European Healthcare Conference |
| 2023-09-12 09:40 am | Baird Global Healthcare Conference |
Past dividends on Revvity, Inc.
| 2024-04-17 | Quarterly 0.07 USD |
| 2024-01-17 | Quarterly 0.07 USD |
| 2023-10-18 | Quarterly 0.07 USD |
| 2023-07-19 | Quarterly 0.07 USD |
| 2023-04-19 | Quarterly 0.07 USD |
| 2023-01-18 | Quarterly 0.07 USD |
| 2022-10-19 | Quarterly 0.07 USD |
| 2022-07-20 | Quarterly 0.07 USD |
| 2022-04-20 | Quarterly 0.07 USD |
| 2022-01-19 | Quarterly 0.07 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 884 2 881 0.12% | 3 784 3 650 3.66% | 5 070 5 020 0.98% | 4 611 4 610 0.01% | 2 751 2 728 0.84% | 2 793 |
|
EBITDA Million USD | Released Forecast Spread | 646 648 -0.29% | 1 257 1 119 12.39% | 1 838 1 779 3.34% | 1 421 1 469 -3.27% | 837 862 -2.98% | 855 |
|
EBIT Million USD | Released Forecast Spread | 596 591 0.83% | 1 203 1 065 12.98% | 1 771 1 695 4.46% | 1 381 1 359 1.65% | 770 766 0.53% | 781 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 237 406 -41.59% | 906 701 29.3% | 1 280 1 269 0.86% | 0,00 0,00 - | 183 218 -16.03% | 337 |
|
Net income Million USD | Released Forecast Spread | 228 275 -17.29% | 728 643 13.23% | 932 990 -5.81% | 579 583 -0.62% | 693 671 3.26% | 246 |
|
EPS USD | Released Forecast Spread | 2,04 2,47 -17.48% | 6,49 5,73 13.2% | 7,99 8,54 -6.48% | 4,58 4,61 -0.64% | 5,55 5,39 3.02% | 1,99 |
| Announcement Date | 27/01/20 | 02/02/21 | 01/02/22 | 14/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 260 1 192 5.71% | 1 230 1 202 2.3% | 1 033 1 037 -0.38% | 1 089 1 072 1.61% | 675 679 -0.52% | 709 708 0.11% | 671 695 -3.39% | 696 680 2.37% | 650 648 0.4% | 693 | 700 | 750 | 702 | 739 |
|
EBITDA Million USD | Released Forecast Spread | 427 376 13.67% | 420 367 14.45% | 283 281 0.71% | 312 323 -3.56% | 206 203 1.79% | 220 224 -1.53% | 202 217 -7.13% | 208 204 2.03% | 182 180 1.52% | 209 | 214 | 248 | 213 | 234 |
|
EBIT Million USD | Released Forecast Spread | 410 359 14.07% | 402 350 14.92% | 272 261 4.08% | 298 281 5.92% | 189 190 -0.43% | 204 206 -0.77% | 185 198 -6.71% | 192 188 1.97% | 166 161 3.05% | 189 | 194 | 231 | 190 | 209 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 29,4 61,7 -52.29% | 71,6 90,6 -21.02% | 50,6 87,1 -41.9% | 31,4 66,3 -52.67% | 34,5 48,6 -28.86% | 70,4 | 65,7 | 105 | 81,6 | 104 | ||||
|
Net income Million USD | Released Forecast Spread | 177 199 -10.92% | 179 198 -9.39% | 85,3 108 -21.29% | 138 141 -2.67% | 569 71,0 701.96% | 35,6 83,8 -57.57% | 9,50 77,2 -87.7% | 78,6 62,9 24.99% | 26,0 41,1 -36.66% | 62,0 | 60,2 | 96,3 | 63,3 | 82,7 |
|
EPS USD | Released Forecast Spread | 1,40 1,51 -7.28% | 1,42 1,62 -12.61% | 0,67 1,06 -36.79% | 1,09 1,18 -7.3% | 4,50 0,57 690.33% | 0,28 0,67 -57.97% | 0,08 0,62 -87.06% | 0,64 0,51 26.11% | 0,21 0,34 -37.31% | 0,50 | 0,49 | 0,78 | 0,52 | 0,68 |
| Announcement Date | 03/05/22 | 01/08/22 | 08/11/22 | 14/02/23 | 11/05/23 | 01/08/23 | 30/10/23 | 01/02/24 | 29/04/24 | - | - | - | - | - |
More events
Past sector events for Revvity, Inc.
| 2024-05-14 | FUKUDA DENSHI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-12 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
| 2024-05-09 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
| 2024-05-08 | JEISYS MEDICAL INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-08 04:05 pm | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:01 pm | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
| 2024-05-08 01:00 am | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
| 2024-05-07 | CLASSYS INC.: Q1 2024 Earnings Release |
| 2024-05-07 04:00 pm | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 06:50 am | WATERS CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RVTY Stock
- Calendar Revvity, Inc.
